<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4"><strong>HTM 01-01: Decontamination of Surgical Instruments (FRCPath Revision Notes)</strong></h1><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Part A – Management and Provision</strong></h2><ul><li><strong>Scope</strong>: Policy and management framework for surgical instrument decontamination in acute care.</li><li><strong>Essential Quality Requirements (EQR)</strong>: Minimum statutory and regulatory compliance (Medical Devices Directive, Care Quality Commission).</li><li><strong>Best Practice</strong>: Beyond EQR, non-mandatory but encouraged for improved safety, efficiency, and innovation.</li><li><strong>Governance</strong>:<ul><li><strong>Director of Infection Prevention and Control (DIPC)</strong> – ultimate responsibility.</li><li><strong>Decontamination lead / surgical instrument manager</strong>.</li><li><strong>AE(D), AP(D), CP(D)</strong> (see below for roles).</li></ul></li><li><strong>Instrument management</strong>:<ul><li>Audit trails, contingency for dropped/unavailable instruments, maintenance of set integrity.</li><li>Instruments used on <strong>high-risk tissues</strong>: separate pools for patients born before vs after 1 Jan 1997 (due to vCJD exposure risk).</li></ul></li><li><strong>Regulatory drivers</strong>: Health &amp; Social Care Act 2008 (Regulated Activities Regulations 2014, Reg. 12(2)(h), Reg. 15).</li><li><strong>Prion-specific policy</strong>:<ul><li>Move towards <strong>in situ residual protein testing</strong>.</li><li>Threshold: <strong>≤5 µg bovine serum albumin (BSA) equivalent per instrument side</strong>.</li><li>Neurosurgical instruments require <strong>stricter thresholds</strong>.</li><li><strong>Implementation deadlines</strong>: by 2017 (neuro/high-risk) and 2018 (all providers).</li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Part B – Common Elements</strong></h2><ul><li><strong>Applies to all reprocessing methods</strong> (sterilization, washer-disinfectors, etc.).</li><li><strong>Covers</strong>:<ul><li><strong>Test equipment &amp; calibration</strong>:<ul><li>UKAS-accredited calibration, ISO/IEC 17025.</li><li>Temperature accuracy ±0.5 °C, pressure ±0.5% absolute.</li><li>Data recorders: ≥180 measurements in 3-min cycle (1/s).</li></ul></li><li><strong>Validation &amp; verification</strong>:<ul><li><strong>Installation Qualification (IQ):</strong> Verifies that equipment is installed correctly to manufacturer’s specifications and site requirements.</li><li><strong>Operational Qualification (OQ):</strong> Demonstrates the equipment operates as intended across the full operating range under test conditions.</li><li><strong>Performance Qualification (PQ):</strong> Confirms the equipment consistently delivers reproducible results with actual loads under routine conditions.</li></ul></li></ul></li><li><strong>Key focus</strong>: ensuring removal of <strong>residual protein</strong>, not just visible soiling.</li><li><strong>Testing</strong>:<ul><li><strong>Daily</strong>: Process challenge devices (PCDs).</li><li><strong>Quarterly</strong>: Residual protein testing (≤5 µg/instrument side).</li></ul></li><li><strong>Priority</strong>: Instruments contacting high prion-risk tissues (Annex J, ACDP-TSE).</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Part C – Steam Sterilization</strong></h2><ul><li><strong>Preferred method</strong>: high-temperature steam (porous-load sterilizers).</li><li><strong>Conditions</strong>:<ul><li>121 °C, 15 min OR 134 °C, 3 min (plateau phase).</li></ul></li><li><strong>Tests</strong>:<ul><li><strong>Daily</strong>: Bowie–Dick test (steam penetration).<ul><li><strong>Purpose</strong>:<ul><li>Daily check of <strong>porous-load steam sterilizers</strong> (autoclaves).</li><li>Confirms <strong>air removal &amp; steam penetration</strong>.</li></ul></li><li><strong>Method</strong>:<ul><li>Use <strong>Bowie–Dick test pack</strong> (towels or commercial chemical indicator sheet/device).</li><li>Place in <strong>empty chamber</strong>, above drain (worst-case position).</li><li>Run cycle: <strong>134 °C for 3.5 min, no drying phase</strong>.</li></ul></li><li><strong>Results</strong>:<ul><li><strong>Pass</strong> = uniform colour change (adequate steam penetration).</li><li><strong>Fail</strong> = patchy colour change (air pockets, vacuum pump failure, non-condensable gases).</li></ul></li><li><strong>Standards</strong>:<ul><li>Required under <strong>HTM 01-01</strong> and <strong>EN 285</strong>.</li><li>Part of <strong>daily QA</strong> for surgical instrument sterilizers.</li></ul></li><li><strong>Scope</strong>:<ul><li>Applies to <strong>all surgical instruments processed in porous-load autoclaves</strong>.</li><li><strong>Not used for flexible endoscopes</strong> → EWDs use <strong>process challenge devices, protein residual testing, microbiological water tests</strong>.</li></ul></li></ul></li><li><strong>Weekly</strong>: Air leakage test, automatic control test.</li><li><strong>Quarterly</strong>: Calibration, thermometric test (small load).</li><li><strong>Yearly</strong>: Full revalidation, including steam quality (dryness, non-condensable gases).</li></ul></li><li><strong>Validation</strong>: per BS EN 285 and ISO 17665.</li><li><strong>Critical factors</strong>:<ul><li>Removal of air/non-condensable gases (air detector required).</li><li>Steam quality: dryness fraction ≥0.95, non-condensable gases ≤3.5%.</li></ul></li><li><strong>Prion relevance</strong>: Steam sterilization alone does <strong>not inactivate prions</strong> → reliance on prior protein removal critical.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Part D – Washer-Disinfectors</strong></h2><ul><li><strong>Purpose</strong>: Automated cleaning &amp; disinfection before sterilization.</li><li><strong>Process</strong>:<ul><li>Cleaning → microbial inactivation (thermal or chemical).</li><li>Drying integral or via separate cabinets.</li></ul></li><li><strong>Design considerations</strong>:<ul><li>Single- vs multi-chamber.</li><li>Critical variables: detergent dosing, pump pressure, water quality, cycle duration.</li></ul></li><li><strong>Tests</strong>:<ul><li><strong>Daily</strong>: PCDs (simulate prion protein adhesion).</li><li><strong>Quarterly</strong>: Residual protein test.</li><li>Continuous monitoring with trend analysis (not pass/fail).</li></ul></li><li><strong>Prion-specific guidance</strong>:<ul><li>Aim for <strong>≤5 µg protein per instrument side</strong>.</li><li>Elution/swabbing methods (ninhydrin, ATP assays) <strong>not acceptable</strong>.</li><li>Instruments should be kept moist post-procedure to aid prion removal.</li></ul></li><li><strong>Regulation</strong>: BS EN ISO 15883 (washer-disinfectors).</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Part E – Low Temperature (Non-Steam) Sterilization</strong></h2><ul><li><strong>Scope</strong>: For <strong>thermolabile devices</strong> (damaged by steam).</li><li><strong>Methods</strong>:<ul><li><strong>Vapourised hydrogen peroxide (VHP) plasma</strong>.</li><li><strong>Ethylene oxide (ETO)</strong>.</li><li><strong>Ozone</strong> (emerging).</li></ul></li><li><strong>Considerations</strong>:<ul><li>Device compatibility essential (plastics, optics).</li><li>Safety: toxic residues (ETO requires long aeration).</li><li>Regulatory oversight: CE-marking, MHRA conformity.</li></ul></li><li><strong>Role in prion risk</strong>:<ul><li>Not proven to inactivate prions.</li><li>Thus, <strong>protein removal in washer-disinfectors is essential before low-T sterilization</strong>.</li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>Prions – Core Notes (cross-cutting all parts)</strong></h2><ul><li><strong>Pathogen</strong>: Transmissible spongiform encephalopathies (TSEs), incl. vCJD.</li><li><strong>Risks</strong>: Standard sterilization insufficient → require meticulous cleaning.</li><li><strong>Policy drivers</strong>: ACDP-TSE guidance (Annex C, J).</li><li><strong>Protein detection threshold</strong>: ≤5 µg BSA equivalent/instrument side.</li><li><strong>Testing</strong>:<ul><li>PCDs mimicking prion adhesion.</li><li>In situ detection methods (still developing).</li></ul></li><li><strong>Priority instruments</strong>:<ul><li>Neurosurgery, ophthalmology, tonsillectomy, and other high-prion-risk procedures.</li></ul></li><li><strong>Operational measures</strong>:<ul><li>Minimise time to decontamination.</li><li>Keep instruments moist post-use.</li><li>Segregated pools for neuro sets depending on patient DOB (before/after 1997).</li></ul></li></ul>
</div>